Skip to main content
Signal8
Brenner Robert profile photo

Robert Brenner

CIK: 0002006910

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (33.3%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Vera Therapeutics, Inc. logo
VERA

Vera Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Vera Therapeutics, Inc. logo
    VERA

    Vera Therapeutics, Inc.

    Feb 23, 2026
    Sale(S)
    Direct
    2.2K shares at avg. $41.98$90K
  • Vera Therapeutics, Inc. logo
    VERA

    Vera Therapeutics, Inc.

    Feb 4, 2026
    Award(A)
    Direct
    25K shares-
  • Vera Therapeutics, Inc. logo
    VERA

    Vera Therapeutics, Inc.

    Feb 18, 2025
    Award(A)
    Direct
    26.9K shares-

1-3 of 3

About Brenner Robert

Brenner Robert (SEC CIK 0002006910) files insider reports with the SEC as Chief Medical Officer of Vera Therapeutics, Inc. (VERA).

Signal8 holds 3 ownership filings by Brenner Robert, all Form 4s, filed between Feb 20, 2025 and Feb 25, 2026. Those filings report 3 transactions, from Feb 18, 2025 to Feb 23, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Brenner Robert's filings is in BRISBANE, CA.

Recent filings by Brenner Robert

  • Feb 23, 2026: Open-market sale of VERA shares (Form 4, code S).
  • Feb 4, 2026: Grant or award of VERA shares (Form 4, code A).
  • Feb 18, 2025: Grant or award of VERA shares (Form 4, code A).

Other insiders filing for Vera Therapeutics, Inc. (VERA)

How to read Form 4 transaction codes